Completed
Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors
NCT04172454
- Conditions
- Advanced Solid Tumors, Melanoma, Neoplasms, +10 more
- Locations
-
- Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China